HFEA/LinkedIn
Jun 18, 2026, 13:25
Zoe’s Experience Living With The Antiphospholipid Syndrome – HFEA
Human Fertilisation and Embryology Authority (HFEA) shared a post on LinkedIn:
”Antiphospholipid syndrome (APS) is a rare autoimmune disorder affecting around 1 in 2000 people in the UK. It increases the risk of blood clots in various parts of the body. In our latest blog, Zoe, a member of our Patient Engagement Forum, shares her experience living with the condition and the impact that it has had on her fertility journey.
Read Zoe’s blog.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic
